3Leitieh H, Kaider A. Fetal fibroneectin how useful is it in the prediction of preterm birth? B JOG, 2008(110):66-70.
4Calda P, Cibula D. Fetal fibronectin in cervical-vaginal secretions all indicator of incipient premature labor usin$ a membrane immtmoassay. Ceska Gnikol, 2009,60(6):293-295.
3Iams J D.Prediction and early detection of preterm labor[J].Obstet Gynecol,2003,101(2):402-412.
4Rinehart B K,Terrone D A,Isler C M,et al.Pregmancy outcome in women with preterm labor symptoms without cervical change[J].Am J Obstet Gynecol,2001,184(5):1004-1007.
5Hartmann P,Thorp J M,Mcdonald T L,Cervial dimensions and risk of preterm birth:A prospective cohort study[J].Obstet Gynecol,1999,93(4):504-509.
6Lockwood CJ, Senyei AE, Dische MR, et al. Fetal fibronectin in cervical and vaginal secretions defines a patient populations at high risk for preterm delivery. N Engl J Med, 1991,325: 669-674.
7Iams JD. Prediction and early detection of preterm birth. Obstet Gynecol, 2003, 101,402-412.
8Leitich H，Kaider A．Fetal fibronectin-how useful is it in the prediction of preterm birth? BJOG,2003，110:66—70．
9Goldenberg RL, Hauth JC, Andrew WW. intrauterine infection and preterm delivery. N Engl J Med, 2000,342: 1500-1507.
10Joffe GM, Jacques D, Bemis-Heys R, et al. Impact of the fetal fibroneetin assay on admissions for preterm labor. Am J Obstet Gynecol, 1999,180:581-586.
1Asskura H, Fukami T, Kurashina R, et al. Significance of cervical gland area in predicting preterm birth for patients with threatened preterm delivery, comparison with cervical length and fetal fibronectin [J] . Gynecol Obstet Invest, 2009, 68 (1): 1-8.
